{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T16:04:41Z","timestamp":1793376281838,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T00:00:00Z","timestamp":1539993600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Microbiol Immunol"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s00430-018-0568-8","type":"journal-article","created":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T00:30:41Z","timestamp":1539995441000},"page":"641-650","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Different roles of CXCR1 and CXCR2 in HTLV-1 carriers and HTLV-1-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) patients"],"prefix":"10.1007","volume":"208","author":[{"given":"Taraneh","family":"Rajaei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Farajifard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Abdolrahim","family":"Rezaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud Reza","family":"Azarpazhooh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Mahmoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narges","family":"Valizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houshang","family":"Rafatpanah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,20]]},"reference":[{"key":"568_CR1","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0952-7915(00)00107-2","volume":"12","author":"CR Bangham","year":"2000","unstructured":"Bangham CR (2000) The immune response to HTLV-I. Curr Opin Immunol 12:397\u2013402. (doi: S0952-7915(00)00107-2 [pii])","journal-title":"Curr Opin Immunol"},{"key":"568_CR2","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/S1473-3099(07)70081-6","volume":"7","author":"K Verdonck","year":"2007","unstructured":"Verdonck K, Gonzalez E, Van Dooren S et al (2007) Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect Dis 7:266\u2013281. https:\/\/doi.org\/10.1016\/S1473-3099(07)70081-6","journal-title":"Lancet Infect Dis"},{"key":"568_CR3","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jcv.2011.07.004","volume":"52","author":"H Rafatpanah","year":"2011","unstructured":"Rafatpanah H, Hedayati-Moghaddam MR, Fathimoghadam F et al (2011) High prevalence of HTLV-I infection in Mashhad, Northeast Iran: a population-based seroepidemiology survey. J Clin Virol 52:172\u2013176. https:\/\/doi.org\/10.1016\/j.jcv.2011.07.004","journal-title":"J Clin Virol"},{"key":"568_CR4","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.it.2007.09.006","volume":"29","author":"B Asquith","year":"2008","unstructured":"Asquith B, Bangham CR (2008) How does HTLV-I persist despite a strong cell-mediated immune response? Trends Immunol 29:4\u201311. https:\/\/doi.org\/10.1016\/j.it.2007.09.006","journal-title":"Trends Immunol"},{"key":"568_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.expneurol.2009.11.019","volume":"225","author":"J Herz","year":"2010","unstructured":"Herz J, Zipp F, Siffrin V (2010) Neurodegeneration in autoimmune CNS inflammation. Exp Neurol 225:9\u201317. https:\/\/doi.org\/10.1016\/j.expneurol.2009.11.019","journal-title":"Exp Neurol"},{"key":"568_CR6","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/j.1440-1789.2010.01135.x","volume":"30","author":"S Izumo","year":"2010","unstructured":"Izumo S (2010) Neuropathology of HTLV-1-associated myelopathy (HAM\/TSP): The 50th Anniversary of Japanese Society of Neuropathology. Neuropathology 30:480\u2013485. https:\/\/doi.org\/10.1111\/j.1440-1789.2010.01135.x","journal-title":"Neuropathology"},{"key":"568_CR7","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.4049\/jimmunol.172.3.1735","volume":"172","author":"PKC Goon","year":"2004","unstructured":"Goon PKC, Igakura T, Hanon E et al (2004) Human T cell lymphotropic Virus type I (HTLV-I)-specific CD4 + T cells: immunodominance hierarchy and preferential infection with HTLV-I. J Immunol 172:1735\u20131743. https:\/\/doi.org\/10.4049\/jimmunol.172.3.1735","journal-title":"J Immunol"},{"key":"568_CR8","doi-asserted-by":"publisher","first-page":"98","DOI":"10.2174\/187152808785107642","volume":"7","author":"DU Goncalves","year":"2008","unstructured":"Goncalves DU, Proietti FA, Barbosa-Stancioli EF et al (2008) HTLV-1-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) inflammatory network. Inflamm Allergy Drug Targets 7:98\u2013107","journal-title":"Inflamm Allergy Drug Targets"},{"key":"568_CR9","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1007\/s11481-010-9216-9","volume":"5","author":"E Matsuura","year":"2010","unstructured":"Matsuura E, Yamano Y, Jacobson S (2010) Neuroimmunity of HTLV-I Infection. J Neuroimmune Pharmacol 5:310\u2013325. https:\/\/doi.org\/10.1007\/s11481-010-9216-9","journal-title":"J Neuroimmune Pharmacol"},{"key":"568_CR10","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/ni.f.214","volume":"9","author":"F Sallusto","year":"2008","unstructured":"Sallusto F, Baggiolini M (2008) Chemokines and leukocyte traffic. Nat Immunol 9:949\u2013952. https:\/\/doi.org\/10.1038\/ni.f.214","journal-title":"Nat Immunol"},{"key":"568_CR11","doi-asserted-by":"crossref","first-page":"5682","DOI":"10.4049\/jimmunol.153.12.5682","volume":"153","author":"A Chuntharapai","year":"1994","unstructured":"Chuntharapai A, Lee J, H\u00e9bert CA, Kim KJ (1994) Monoclonal antibodies detect different distribution patterns of IL-8 receptor A and IL-8 receptor B on human peripheral blood leukocytes. J Immunol 153:5682\u20135688","journal-title":"J Immunol"},{"key":"568_CR12","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1189\/jlb.1003495","volume":"76","author":"SL Traves","year":"2004","unstructured":"Traves SL, Smith SJ, Barnes PJ, Donnelly LE (2004) Specific CXC but not CC chemokines cause elevated monocyte migration in COPD: a role for CXCR2. J Leukoc Biol 76:441\u2013450. https:\/\/doi.org\/10.1189\/jlb.1003495","journal-title":"J Leukoc Biol"},{"key":"568_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/08820139.2013.812652","volume":"8","author":"S Almasi","year":"2013","unstructured":"Almasi S, Aliparasti MR, Zamani F, Sadeghi-bazargani H (2013) Quantitative evaluation of CXCL8 and its receptors (CXCR1 and CXCR2) gene expression in Iranian patients with multiple sclerosis. Immunol Investig 8 1\u201312. https:\/\/doi.org\/10.3109\/08820139.2013.812652","journal-title":"Immunol Investig"},{"key":"568_CR14","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s10875-007-9142-7","volume":"28","author":"B Bielecki","year":"2008","unstructured":"Bielecki B, Mazurek A, Wolinski P, Glabinski A (2008) Treatment of multiple sclerosis with methylprednisolone and mitoxantrone modulates the expression of CXC chemokine receptors in PBMC. J Clin Immunol 28:122\u2013130. https:\/\/doi.org\/10.1007\/s10875-007-9142-7","journal-title":"J Clin Immunol"},{"issue":"5","key":"568_CR15","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1093\/brain\/awh479","volume":"128","author":"KM Omari","year":"2005","unstructured":"Omari KM, John GR, Sealfon SC, Raine CS (2005) CXC chemokine receptors on human oligodendrocytes: implications for multiple sclerosis. Brain 128(5) 1003\u20131015","journal-title":"Brain"},{"key":"568_CR16","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/jcbfm.2009.240","volume":"30","author":"BD Semple","year":"2010","unstructured":"Semple BD, Kossmann T, Morganti-Kossmann MC (2010) Role of chemokines in CNS health and pathology: a focus on the CCL2\/CCR2 and CXCL8\/CXCR2 networks. J Cereb Blood Flow Metab 30:459\u2013473. https:\/\/doi.org\/10.1038\/jcbfm.2009.240","journal-title":"J Cereb Blood Flow Metab"},{"key":"568_CR17","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1056\/NEJMra052723","volume":"354","author":"IF Charo","year":"2006","unstructured":"Charo IF, Ransohoff RM (2006) The Many Roles of Chemokines and chemokine receptors in inflammation. N Engl J Med 354:610\u2013621. https:\/\/doi.org\/10.1056\/NEJMra052723","journal-title":"N Engl J Med"},{"key":"568_CR18","doi-asserted-by":"publisher","first-page":"e11340","DOI":"10.1371\/journal.pone.0011340","volume":"5","author":"MP Hosking","year":"2010","unstructured":"Hosking MP, Tirotta E, Ransohoff RM, Lane TE (2010) CXCR2 signaling protects oligodendrocytes and restricts demyelination in a mouse model of viral-induced demyelination. Plos ONE 5: e11340. https:\/\/doi.org\/10.1371\/journal.pone.0011340","journal-title":"Plos ONE"},{"key":"568_CR19","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.4049\/jimmunol.162.3.1765","volume":"162","author":"K Bieganowska","year":"1999","unstructured":"Bieganowska K, H\u00f6llsberg P, Buckle GJ et al (1999) Direct analysis of viral-specific CD8 + T cells with soluble HLA-A2\/Tax11-19 tetramer complexes in patients with human T cell lymphotropic virus-associated myelopathy. J Immunol 162:1765\u20131771","journal-title":"J Immunol"},{"key":"568_CR20","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jneuroim.2012.05.004","volume":"250","author":"H Rafatpanah","year":"2012","unstructured":"Rafatpanah H, Rezaee A, Etemadi MM et al (2012) The impact of interferon-alpha treatment on clinical and immunovirological aspects of HTLV-1-associated myelopathy in northeast of Iran. J Neuroimmunol 250:87\u201393. https:\/\/doi.org\/10.1016\/j.jneuroim.2012.05.004","journal-title":"J Neuroimmunol"},{"key":"568_CR21","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/NEN.0000000000000141","volume":"74","author":"E Matsuura","year":"2015","unstructured":"Matsuura E, Kubota R, Tanaka Y et al (2015) Visualization of HTLV-1-specific cytotoxic T lymphocytes in the spinal cords of patients with HTLV-1-associated myelopathy\/tropical spastic paraparesis. J Neuropathol Exp Neurol 74:2\u201314. https:\/\/doi.org\/10.1097\/NEN.0000000000000141","journal-title":"J Neuropathol Exp Neurol"},{"key":"568_CR22","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.1182\/blood-2002-08-2477","volume":"101","author":"R Kubota","year":"2003","unstructured":"Kubota R, Furukawa Y, Izumo S et al (2003) Degenerate specificity of HTLV-1-specific CD8 + T cells during viral replication in patients with HTLV-1-associated myelopathy (HAM\/TSP). Blood 101:3074\u20133081. https:\/\/doi.org\/10.1182\/blood-2002-08-2477","journal-title":"Blood"},{"key":"568_CR23","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.4049\/jimmunol.169.3.1550","volume":"169","author":"JS Haring","year":"2002","unstructured":"Haring JS, Pewe LL, Perlman S (2002) Bystander CD8 T cell-mediated demyelination after viral infection of the central nervous system. J Immunol 169:1550\u20131555. https:\/\/doi.org\/10.4049\/jimmunol.169.3.1550","journal-title":"J Immunol"},{"key":"568_CR24","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/0306-9877(93)90111-3","volume":"41","author":"S Ijichi","year":"1993","unstructured":"Ijichi S, Izumo S, Eiraku N et al (1993) An autoaggressive process against bystander tissues in HTLV-I-infected individuals: A possible pathomechanism of HAM TSP. Med Hypotheses 41:542\u2013547. https:\/\/doi.org\/10.1016\/0306-9877(93)90111-3","journal-title":"Med Hypotheses"},{"key":"568_CR25","first-page":"2","volume":"16","author":"R Vakili","year":"2013","unstructured":"Vakili R, Sabet F, Ghezeldasht SA et al (2013) Human T-lymphotropic Virus Type I (HTLV-I) proviral load and clinical features in Iranian HAM\/TSP Patients. Iran J Basic Med Sci 16 2\u20136","journal-title":"Iran J Basic Med Sci"},{"key":"568_CR26","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1084\/jem.20072404","volume":"205","author":"T Carlson","year":"2008","unstructured":"Carlson T, Kroenke M, Rao P et al (2008) The Th17-ELR + CXC chemokine pathway is essential for the development of central nervous system autoimmune disease. J Exp Med 205:811\u2013823. https:\/\/doi.org\/10.1084\/jem.20072404","journal-title":"J Exp Med"},{"key":"568_CR27","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.virol.2006.08.003","volume":"358","author":"N Rubio","year":"2007","unstructured":"Rubio N, Sanz-Rodriguez F (2007) Induction of the CXCL1 (KC) chemokine in mouse astrocytes by infection with the murine encephalomyelitis virus of Theiler. Virology 358:98\u2013108. https:\/\/doi.org\/10.1016\/j.virol.2006.08.003","journal-title":"Virology"},{"key":"568_CR28","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/glia.20246","volume":"53","author":"KM Omari","year":"2006","unstructured":"Omari KM, John G, Lango R, Raine CS (2006) Role for CXCR2 and CXCL1 on glia in multiple sclerosis. Glia 53:24\u201331. https:\/\/doi.org\/10.1002\/glia.20246","journal-title":"Glia"},{"key":"568_CR29","first-page":"617","volume":"150","author":"R Glabinski a","year":"1997","unstructured":"Glabinski a R, Tani M, Strieter RM et al (1997) Synchronous synthesis of alpha- and beta-chemokines by cells of diverse lineage in the central nervous system of mice with relapses of chronic experimental autoimmune encephalomyelitis. Am J Pathol 150:617\u2013630","journal-title":"Am J Pathol"},{"key":"568_CR30","doi-asserted-by":"publisher","first-page":"164","DOI":"10.2353\/ajpath.2009.080350","volume":"174","author":"KM Omari","year":"2009","unstructured":"Omari KM, Lutz SE, Santambrogio L et al (2009) Neuroprotection and remyelination after autoimmune demyelination in mice that inducibly overexpress CXCL1. Am J Pathol 174:164\u2013176. https:\/\/doi.org\/10.2353\/ajpath.2009.080350","journal-title":"Am J Pathol"},{"key":"568_CR31","doi-asserted-by":"publisher","first-page":"e1000648","DOI":"10.1371\/journal.ppat.1000648","volume":"5","author":"MP Hosking","year":"2009","unstructured":"Hosking MP, Liu L, Ransohoff RM, Lane TE (2009) A protective role for ELR + chemokines during acute viral encephalomyelitis. PLoS Pathog 5:e1000648. https:\/\/doi.org\/10.1371\/journal.ppat.1000648","journal-title":"PLoS Pathog"},{"key":"568_CR32","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/nn.2491","volume":"13","author":"L Liu","year":"2010","unstructured":"Liu L, Belkadi A, Darnall L et al (2010) CXCR2-positive neutrophils are essential for cuprizone-induced demyelination: relevance to multiple sclerosis. Nat Neurosci 13:319\u2013326. https:\/\/doi.org\/10.1038\/nn.2491","journal-title":"Nat Neurosci"},{"key":"568_CR33","doi-asserted-by":"publisher","first-page":"9074","DOI":"10.1523\/JNEUROSCI.1238-10.2010","volume":"30","author":"L Liu","year":"2010","unstructured":"Liu L, Darnall L, Hu T et al (2010) Myelin repair is accelerated by inactivating CXCR2 on nonhematopoietic cells. J Neurosci 30:9074\u20139083. https:\/\/doi.org\/10.1523\/JNEUROSCI.1238-10.2010","journal-title":"J Neurosci"},{"key":"568_CR34","doi-asserted-by":"publisher","first-page":"3730","DOI":"10.1016\/j.febslet.2011.04.037","volume":"585","author":"JR Patel","year":"2011","unstructured":"Patel JR, Klein RS (2011) Mediators of oligodendrocyte differentiation during remyelination. FEBS Lett 585:3730\u20133737","journal-title":"FEBS Lett"},{"key":"568_CR35","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.expneurol.2009.07.010","volume":"220","author":"AE Kerstetter","year":"2009","unstructured":"Kerstetter AE, Padovani-Claudio DA, Bai L, Miller RH (2009) Inhibition of CXCR2 signaling promotes recovery in models of multiple sclerosis. Exp Neurol 220:44\u201356. https:\/\/doi.org\/10.1016\/j.expneurol.2009.07.010","journal-title":"Exp Neurol"},{"key":"568_CR36","doi-asserted-by":"publisher","first-page":"23830","DOI":"10.1074\/jbc.273.37.23830","volume":"273","author":"RM Richardson","year":"1998","unstructured":"Richardson RM, Pridgen BC, Haribabu B et al (1998) Differential cross-regulation of the human chemokine receptors CXCR1 and CXCR2. Evidence for time-dependent signal generation. J Biol Chem 273:23830\u201323836. https:\/\/doi.org\/10.1074\/jbc.273.37.23830","journal-title":"J Biol Chem"},{"key":"568_CR37","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.4049\/jimmunol.155.5.2587","volume":"155","author":"A Chuntharapai","year":"1995","unstructured":"Chuntharapai A, Kim KJ (1995) Regulation of the expression of IL-8 receptor A\/B by IL-8: possible functions of each receptor. J Immunol 155:2587\u20132594","journal-title":"J Immunol"},{"key":"568_CR38","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.4049\/jimmunol.158.3.1361","volume":"158","author":"I Sabroe","year":"1997","unstructured":"Sabroe I, Williams TJ, H\u00e9bert CA, Collins PD (1997) Chemoattractant cross-desensitization of the human neutrophil IL-8 receptor involves receptor internalization and differential receptor subtype regulation. J Immunol 158:1361\u20131369","journal-title":"J Immunol"},{"key":"568_CR39","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.7150\/thno.15625","volume":"7","author":"H Ha","year":"2017","unstructured":"Ha H, Debnath B, Neamati N (2017) Role of the CXCL8-CXCR1\/2 axis in cancer and inflammatory diseases. Theranostics 7:1543\u20131588","journal-title":"Theranostics"},{"key":"568_CR40","first-page":"3993","volume":"58","author":"N Mori","year":"1998","unstructured":"Mori N, Mukaida N, Ballard DW et al (1998) Human T-cell leukemia virus type I Tax transactivates human interleukin 8 gene through acting concurrently on AP-1 and nuclear factor-kappa B-like sites. Cancer Res 58:3993\u20134000","journal-title":"Cancer Res"},{"key":"568_CR41","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3109\/10428199609093442","volume":"21","author":"Y Yamada","year":"1996","unstructured":"Yamada Y, Ohmoto Y, Hata T et al (1996) Features of the cytokines secreted by adult T cell leukemia (ATL) cells. Leuk Lymphoma 21:443\u2013447. https:\/\/doi.org\/10.3109\/10428199609093442","journal-title":"Leuk Lymphoma"},{"key":"568_CR42","first-page":"1816","volume":"50","author":"S Okamoto","year":"1992","unstructured":"Okamoto S, Nomura H, Matsushima K (1992) Function, molecular structure and gene expression of IL-8. Nippon Rinsho 50:1816\u20131820","journal-title":"Nippon Rinsho"},{"key":"568_CR43","doi-asserted-by":"publisher","first-page":"502","DOI":"10.3109\/1354750X.2015.1094141","volume":"20","author":"ALB Starling","year":"2015","unstructured":"Starling ALB, Coelho-Dos-Reis JGA, Peruhype-Magalh\u00e3es V et al (2015) Immunological signature of the different clinical stages of the HTLV-1 infection: establishing serum biomarkers for HTLV-1-associated disease morbidity. Biomarkers 20:502\u2013512. https:\/\/doi.org\/10.3109\/1354750X.2015.1094141","journal-title":"Biomarkers"},{"key":"568_CR44","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1002\/jmv.24481","volume":"88","author":"DG Chaves","year":"2016","unstructured":"Chaves DG, Sales CC, de C\u00e1ssia Gon\u00e7alves P et al (2016) Plasmatic proinflammatory chemokines levels are tricky markers to monitoring HTLV-1 carriers. J Med Virol 88:1438\u20131447. https:\/\/doi.org\/10.1002\/jmv.24481","journal-title":"J Med Virol"},{"key":"568_CR45","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/eji.200636251","volume":"37","author":"T Kondo","year":"2007","unstructured":"Kondo T, Takata H, Takiguchi M (2007) Functional expression of chemokine receptor CCR6 on human effector memory CD8 + T cells. Eur J Immunol 37:54\u201365. https:\/\/doi.org\/10.1002\/eji.200636251","journal-title":"Eur J Immunol"}],"container-title":["Medical Microbiology and Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-018-0568-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00430-018-0568-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-018-0568-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T06:03:16Z","timestamp":1693980196000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00430-018-0568-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,20]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["568"],"URL":"https:\/\/doi.org\/10.1007\/s00430-018-0568-8","relation":{},"ISSN":["0300-8584","1432-1831"],"issn-type":[{"value":"0300-8584","type":"print"},{"value":"1432-1831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,20]]},"assertion":[{"value":"6 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"There is no conflict of interest for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee. The study was approved by ethics committee of Mashhad University of Medical sciences, Mashhad (No. 89659).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}